Description
Hyperforin DCHA is a stable salt form of hyperforin, a compound found in Hypericum perforatum (St. John’s Wort). Hyperforin DCHA exhibits anticancer, anti-inflammatory, and antidepressant activities. In chronic myelogenous leukemia (CML) cells, hyperforin DCHA disrupts the mitochondrial membrane potential, increases release of cytochrome c, activates caspases 3, 8, and 9, and induces cleavage of poly(ADP)-ribose polymerase (PARP), resulting in G1 phase cell cycle arrest and apoptosis. In astrocytoma cells, hyperforin DCHA prevents LPS- and substance P-induced release of IL-6. In animal models, this compound prevents croton oil-induced edema. Additionally, hyperforin DCHA decreases immobility time in animals undergoing the forced swim test.
References
Liu JY, Liu Z, Wang DM, et al. Induction of apoptosis in K562 cells by dicyclohexylammonium salt of hyperforin through a mitochondrial-related pathway. Chem Biol Interact. 2011 Apr 25;190(2-3):91-101. PMID: 21376709.
Sosa S, Pace R, Bornancin A, et al. Topical anti-inflammatory activity of extracts and compounds from Hypericum perforatum L. J Pharm Pharmacol. 2007 May;59(5):703-9. PMID: 17524236.
Gobbi M, Moia M, Funicello M, et al. In vitro effects of the dicyclohexylammonium salt of hyperforin on interleukin-6 release in different experimental models. Planta Med. 2004 Jul;70(7):680-2. PMID: 15303261.
Cervo L, Rozio M, Ekalle-Soppo CB, et al. Role of hyperforin in the antidepressant-like activity of Hypericum perforatum extracts. Psychopharmacology (Berl). 2002 Dec;164(4):423-8. PMID: 12457273.
